Outgoing AbbVie CEO leaves a divisive Humira legacy and lasting impact on pharma
BioPharma
Stay updated with breaking news from Robert Michael. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbbVie is looking to sell at least $13 billion of corporate bonds to help fund its acquisitions of ImmunoGen and Cerevel Therapeutics, Bloomberg News reported on Wednesday, citing people...
Pharmaceutical giant AbbVie Inc. is looking to sell at least $13 billion of corporate bonds to help fund its acquisitions of ImmunoGen Inc. and Cerevel Therapeutics Holdings Inc., according to people with knowledge of the matter.
(CTN News) - AbbVie announced on Tuesday that long-time executive Robert Michael would replace Richard Gonzalez as its new..............
AbbVie said on Tuesday that its chief operating officer Robert Michael would succeed Richard Gonzalez as chief executive officer of the drugmaker on July 1.…